The healthcare industry has witnessed significant technological advancements over the past decade, and e-prescribing is one of the most transformative. E-prescribing involves the digital creation and transmission of prescription information from healthcare providers to pharmacies, streamlining the medication prescribing process. The history of e-prescribing shows evolution, from the foundational steps, the progress in electronic prescribing of controlled substances, and towards the future innovations expected to enhance this technology further.
Laying the Foundation for E-Prescribing
The journey of e-prescribing began with relatively simple systems that few prescribers utilised. Initially, most healthcare providers relied on traditional paper-based methods to prescribe medications, which often led to issues such as handwriting errors, delays in prescription fulfilment, and potential medication errors. Recognising the need for modernisation, the U.S. Congress passed the Medicare Modernization Act in 2003, allowing for the electronic prescribing of medications. This legislative move was followed by the enactment of state laws in 2006, permitting e-prescribing of most legend drugs, which are medications that require a prescription.
A significant boost to e-prescribing came with the Medicare Improvements for Patients and Providers Act (MIPPA) in 2008, which introduced financial incentives for healthcare providers adopting e-prescribing. The Health Information Technology for Economic and Clinical Health (HITECH) Act of 2009 further accelerated the adoption of Health IT systems, including Electronic Health Records (EHRs) that integrated e-prescribing functionalities. By 2010, the Drug Enforcement Administration (DEA) issued rules allowing the electronic prescribing of controlled substances (EPCS), expanding the scope of e-prescribing to include more medications.
The combined impact of these policies and advancements led to a dramatic increase in e-prescribing adoption. By 2021, 92% of prescribers were using e-prescribing systems, a significant rise from the mere 7% in 2008. This widespread adoption not only enhanced the efficiency of the prescribing process but also significantly reduced medication errors and improved patient safety.
Advancements in E-Prescribing of Controlled Substances
The introduction of EPCS has been a critical development in the fight against the opioid epidemic and other issues related to controlled substances. EPCS allows prescribers to electronically send prescriptions for controlled substances, which was previously restricted due to concerns over security and fraud. The DEA's 2010 rulemaking opened the door for electronic management of these prescriptions, providing a secure and efficient alternative to traditional paper prescriptions.
The EPCS system integrates with Prescription Drug Monitoring Programs (PDMPs), which are state-run programmes that track the prescribing and dispensing of controlled prescription drugs. This integration helps healthcare providers monitor patient prescriptions, reducing the risk of doctor shopping and overprescribing. The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act of 2018 mandated the use of EPCS for Medicare Part D providers, further promoting the adoption of this technology.
Today, the adoption of EPCS is widespread, with 82% of prescribers and nearly all pharmacies enabled to handle electronic prescriptions for controlled substances. This capability not only improves patient safety by reducing the risk of prescription fraud and abuse but also enhances workflow efficiency and reduces administrative burdens on healthcare providers.
Future Directions and Innovations in E-Prescribing
Despite the considerable progress made in e-prescribing, areas remain for improvement and innovation. One of the critical areas for future development is the inclusion of comprehensive prescription information, such as the indication or reason for the medication. Currently, most e-prescriptions include details like dosage, strength, quantity, and route of administration but often omit the purpose of the medication. Including this information can enhance the quality of care by enabling pharmacists to provide more personalised and informed care, ensuring that the prescribed treatment aligns with the patient’s specific health needs.
Another critical area for advancement is the enhancement of bi-directional data flow between healthcare providers and pharmacies. This capability would allow for real-time updates on prescription status, adherence issues, and potential drug interactions, providing a more comprehensive view of the patient's medication history. The Health Information Technology Advisory Committee (HITAC) has recommended implementing advanced interoperability features, such as real-time benefit tools (RTBT) that provide patient-specific cost and coverage information. These tools can help prescribers make more informed decisions, particularly regarding the affordability and accessibility of prescribed medications for patients.
Furthermore, there is a growing need to address patient privacy and data security within the e-prescribing system. As more sensitive health information is shared electronically, robust measures must be in place to protect patient data. The proposed Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing, and Public Health Interoperability (HTI-2) rule aims to address these concerns by ensuring that patient-specific cost and coverage information is securely conveyed through RTBTs and that indications are included in e-prescriptions.
The past decade has seen a significant transformation in e-prescribing, driven by technological advancements and supportive policy frameworks. E-prescribing has become integral to modern healthcare, offering numerous benefits such as increased efficiency, enhanced patient safety, and reduced medication errors. However, there is still room for further innovation, particularly in comprehensive prescription information, improved interoperability, and data security.
Source: HealthIT Answers
Image Credit: iStock
